C4 Therapeutics
CCCC
CCCC
118 hedge funds and large institutions have $1.15B invested in C4 Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $1.54B → $1.15B (-$388M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
118
Holding in Top 10
2
Calls
$1.9M
Puts
–
Top Buyers
| 1 | +$20.2M | |
| 2 | +$15M | |
| 3 | +$8.37M | |
| 4 |
BlackRock
New York
|
+$8.01M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.96M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$9.04M | |
| 3 | -$8.94M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.1M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$3.88M |